跳至主要内容
临床试验/NCT05065112
NCT05065112尚未招募不适用

Individualised MApping-Guided Ablation to Improve Outcomes in pErsistent Atrial Fibrillation

Royal Brompton & Harefield NHS Foundation Trust0 个研究点目标入组 212 人开始时间: 2021年11月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
212
主要终点
Freedom from atrial arrhythmia

研究概览

简要总结

A clinical randomised trial to compare strategies for ablation in persistent and long-standing persistent atrial fibrillation comprising of two arms: pulmonary veins isolation (PVI) only and PVI + individualised mapping-guided ablation (Cartofinder, Biosense Webster Inc.)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years old
  • Signed informed consent.
  • Scheduled to undergo a clinically indicated, first-time catheter ablation procedure for the treatment of persistent atrial fibrillation.
  • In atrial fibrillation at the time of the index procedure.

排除标准

  • Paroxysmal atrial fibrillation.
  • Previous ablation procedure for atrial fibrillation.
  • Left ventricular ejection fraction < 45%
  • Obesity with BMI > 35 kg/m2
  • Congenital heart disease.
  • Previous cardiac surgery with atriotomy.
  • Previous left atrial appendage closure/ligation.
  • Contraindications to systemic anticoagulation, catheter ablation, and/or general anaesthesia.
  • Current enrolment in a study evaluating another device or drug.

结局指标

主要结局

Freedom from atrial arrhythmia

时间窗: 12 monts

Freedom from any atrial arrhythmia without the use of antiarrhythmic drugs

次要结局

  • Freedom from atrial fibrillation(12 months)
  • Atrial fibrillation burden reduction(12 months)
  • Absolute atrial fibrillation burden(12 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验

Individualised Mapping in Persistent AF Ablation | 临床试验